arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

NATIONAL HEALTH INVESTORS INC

NHI

$75.35 ▼ -0.12 (-0.16%) at close

18 Visible periods

35 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Excellent

Bullish

auto_awesome

Analytical Summary

NATIONAL HEALTH INVESTORS INC shows strong fundamentals with top-quartile Profit Margin (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $3.5B

Dividend Yield 4.83%

Revenue Growth 12.1%

Op. Margin None

ROIC None

FCF / Share None

Trailing P/E 24.9x

Price / Book 2.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

18-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$375.63M

↑ +12.1% —

Net Income Profit after all expenses

$142.18M

↑ +3.0% —

Operating Margin Operating profit as % of sales

58.1%

↓ -14.0% —

Long-Term Debt Long-term obligations

$1.13B

↑ +1313.5% —

trending_up

Bullish Indicators

Profit Margin (%)Profit Margin (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Profitability ↓

Returns ↑

Dividend History

Dividend / share · sourced from SEC filings

$3.64 Latest / share

+1.1% YoY

+1.5% 12-yr CAGR

$3.08

FY 2014

$3.40

FY 2015

$3.60

FY 2016

$3.80

FY 2017

$4.00

FY 2018

$4.20

FY 2019

$4.41

FY 2020

$0.90

FY 2021

$0.90

FY 2022

$0.90

FY 2023

$3.60

FY 2024

$3.64

FY 2025

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗	FY 2009 Dec 31, 2008 10-K ↗	FY 2008 Dec 31, 2007 10-K ↗
Revenue Growth YoY (%)	12.1% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+141%)	—	—	—	-10.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-305%)	4.6% Caution ↓ Caution Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-7%)	8.0% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+59%)	5.7% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+14%)	12.1% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+143%)	8.5% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+70%)	29.0% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+480%)	50.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+913%)	40.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+714%)	6.8% Fair ↓ Fair Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+36%)	24.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+383%)	10.9% Good Good Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+118%)	—	—
EPS Growth YoY (%)	-3.5% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.3% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	111.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-39.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-40.8% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	11.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	0.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-5.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.5% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	-2.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	30.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-18.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	27.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	16.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	7.7% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	12.0% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—
Net Income Growth YoY (%)	3.0% Caution ↓ Caution Declining Year-over-year change in net income	1.7% Caution ↓ Caution Declining Year-over-year change in net income	104.3% Excellent ↑ Excellent Improving Year-over-year change in net income	-40.6% Weak ↓ Weak Declining Year-over-year change in net income	-39.6% Weak ↓ Weak Declining Year-over-year change in net income	15.4% Good ↑ Good Improving Year-over-year change in net income	4.0% Caution ↑ Caution Improving Year-over-year change in net income	-3.2% Weak ↓ Weak Declining Year-over-year change in net income	5.2% Fair ↓ Fair Declining Year-over-year change in net income	1.8% Caution ↓ Caution Declining Year-over-year change in net income	46.5% Excellent ↑ Excellent Improving Year-over-year change in net income	-4.3% Weak ↓ Weak Declining Year-over-year change in net income	30.9% Excellent ↑ Excellent Improving Year-over-year change in net income	16.9% Good ↑ Good Improving Year-over-year change in net income	8.1% Fair Fair Year-over-year change in net income	11.7% Fair Fair Year-over-year change in net income	—	—
FCF Growth YoY (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Revenue CAGR 3Y (%)	—	3.9% Caution Caution Compound annual revenue growth over 3 years	—	—	0.5% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	6.1% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	8.6% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	8.8% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	16.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	28.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	39.8% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	31.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	23.1% Excellent Excellent Compound annual revenue growth over 3 years	13.7% Good Good Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	2.5% Caution Caution Compound annual revenue growth over 5 years	1.1% Caution Caution Compound annual revenue growth over 5 years	—	—	3.7% Caution ↓ Caution Declining Compound annual revenue growth over 5 years	7.8% Fair ↓ Fair Declining Compound annual revenue growth over 5 years	12.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	20.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	27.2% Excellent → Excellent Stable Compound annual revenue growth over 5 years	26.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	29.4% Excellent Excellent Compound annual revenue growth over 5 years	25.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	27.0% Excellent ↑ Excellent Improving Compound annual EPS growth over 3 years	8.6% Fair ↑ Fair Improving Compound annual EPS growth over 3 years	-8.9% Weak ↑ Weak Improving Compound annual EPS growth over 3 years	-26.3% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-12.7% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	2.0% Caution ↑ Caution Improving Compound annual EPS growth over 3 years	-1.6% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-2.4% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	8.7% Fair ↑ Fair Improving Compound annual EPS growth over 3 years	1.2% Caution ↓ Caution Declining Compound annual EPS growth over 3 years	10.6% Good ↓ Good Declining Compound annual EPS growth over 3 years	6.6% Fair ↓ Fair Declining Compound annual EPS growth over 3 years	17.1% Excellent Excellent Compound annual EPS growth over 3 years	12.1% Good Good Compound annual EPS growth over 3 years	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗	FY 2009 Dec 31, 2008 10-K ↗	FY 2008 Dec 31, 2007 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	58.1% Excellent ↓ Excellent Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+94%)	67.5% Excellent ↓ Excellent Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+125%)	83.4% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+178%)	74.6% Excellent → Excellent Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+149%)	77.5% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+158%)	78.4% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+161%)	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.7% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	37.9% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+51%)	41.2% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+65%)	—	—	37.4% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+50%)	55.6% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+122%)	50.4% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+102%)	52.4% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+110%)	57.2% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+129%)	61.0% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+144%)	65.0% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+160%)	57.2% Excellent ↓ Excellent Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+129%)	90.1% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+260%)	96.9% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+288%)	88.6% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+254%)	—	—	—
FCF Margin (%) (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FCF / Net Income (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗	FY 2009 Dec 31, 2008 10-K ↗	FY 2008 Dec 31, 2007 10-K ↗
Return on Invested Capital (%) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Capital (%) (%)	—	—	5.5% Caution Caution Operating profit relative to total assets Optimal: > 10%	2.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	5.2% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	5.5% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	9.9% Fair ↓ Fair Declining Operating profit relative to total assets Optimal: > 10%	11.5% Good Good Operating profit relative to total assets Optimal: > 10%	10.7% Good Good Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	9.3% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+17%)	10.1% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+26%)	10.8% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+35%)	5.2% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-35%)	7.4% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-7%)	12.2% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+53%)	10.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+34%)	11.1% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+39%)	—	12.5% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+57%)	13.1% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+64%)	9.8% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+22%)	13.9% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+73%)	17.7% Good Good Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+122%)	—	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗	FY 2009 Dec 31, 2008 10-K ↗	FY 2008 Dec 31, 2007 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	0.94x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-6%)	—	—	0.10x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	0.00x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-100%)	—	—	—	—
Interest Coverage (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Debt (USD)	$-19.62M	$-24.29M	$-22.35M	$-19.29M	$-37.41M	$-43.34M	$-5.21M	$-4.66M	$-3.06M	$1.13B	$-13.29M	$-3.29M	$68.77M	$-15.89M	$-2.66M	$-45.72M	$-100.24M	$-75.36M
Debt / EBITDA (x) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

📊 What does each share earn? 8 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗	FY 2009 Dec 31, 2008 10-K ↗	FY 2008 Dec 31, 2007 10-K ↗
Revenue per Share (USD)	$8.01	$7.64	—	—	$6.53	$7.45	$7.33	$7.02	$6.81	$6.37	$6.09	$5.32	$4.15	$3.02	$2.83	$2.29	$2.06	—
Basic EPS, GAAP (USD)	$3.03	$3.14	$3.13	$1.48	$2.45	$4.14	$3.70	$3.68	$3.90	$3.88	$3.96	$3.04	$3.74	$2.93	$2.51	$2.33	$2.08	—
Free Cash Flow per Share (USD) N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Dividend per Share (USD)	$3.64	$3.60	$0.90	$0.90	$0.90	$4.41	$4.20	$4.00	$3.80	$3.60	$3.40	$3.08	$2.90	$2.71	$2.36	$2.30	$2.42	—
Book Value per Share (USD)	$31.50	$29.91	$28.89	$29.28	$32.87	$33.47	$33.59	$32.55	—	$30.36	$29.52	$27.74	$23.19	$16.41	—	—	—	—
Tangible Book Value per Share (USD)	$31.50	$29.91	$28.89	$29.28	$32.87	$33.47	$33.59	$32.55	—	$30.36	$29.52	$27.74	$23.19	$16.41	—	—	—	—
Basic Weighted Avg Shares (shares)	46.87M	43.84M	43.39M	44.77M	45.71M	44.70M	43.42M	41.94M	40.89M	39.01M	37.60M	33.38M	28.36M	27.72M	27.66M	27.59M	27.71M	—
Dividend Payout Ratio (%)	120.1% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	114.6% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	28.8% Excellent ↓ Excellent Declining Dividends paid as a percentage of earnings Optimal: 30-60%	60.8% Fair ↓ Fair Declining Dividends paid as a percentage of earnings Optimal: 30-60%	36.7% Good ↓ Good Declining Dividends paid as a percentage of earnings Optimal: 30-60%	106.5% Weak → Weak Stable Dividends paid as a percentage of earnings Optimal: 30-60%	113.5% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	—	97.4% Weak → Weak Stable Dividends paid as a percentage of earnings Optimal: 30-60%	92.8% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	85.9% Caution ↓ Caution Declining Dividends paid as a percentage of earnings Optimal: 30-60%	101.3% Weak ↑ Weak Improving Dividends paid as a percentage of earnings Optimal: 30-60%	77.5% Caution Caution Dividends paid as a percentage of earnings Optimal: 30-60%	92.7% Weak Weak Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗	FY 2009 Dec 31, 2008 10-K ↗	FY 2008 Dec 31, 2007 10-K ↗
LT Debt (USD)	—	—	—	—	—	—	—	—	—	$1.13B	—	—	$80.08M	$0.00	—	—	—	—
Total Equity (USD)	$1.52B	$1.37B	$1.25B	$1.27B	$1.51B	$1.51B	$1.50B	$1.39B	—	$1.21B	$1.13B	$1.04B	$766.55M	$457.18M	—	—	—	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗	FY 2009 Dec 31, 2008 10-K ↗	FY 2008 Dec 31, 2007 10-K ↗
Sales/Revenue/Turnover (USD)	$375.63M	$335.18M	—	—	$298.71M	$332.81M	$318.08M	$294.61M	$278.66M	$248.50M	$228.99M	$177.51M	$117.83M	$83.74M	$78.40M	$63.16M	$56.94M	—
Depreciation Expense (USD)	—	—	$69.97M	$70.88M	$80.80M	$83.15M	$76.82M	$71.35M	$67.17M	$59.56M	$53.16M	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$142.18M	$137.99M	$135.65M	$66.40M	$111.80M	$185.13M	$160.46M	$154.33M	$159.37M	$151.54M	$148.86M	$101.61M	$106.18M	$81.13M	$69.42M	$64.23M	$57.51M	—
Operating Cash Flow (USD)	$236.56M	$207.77M	$184.45M	$185.34M	$210.86M	$232.15M	$240.96M	$207.87M	$198.09M	$177.22M	$164.43M	$126.14M	$104.19M	$76.85M	$77.54M	$69.06M	$67.13M	—

🏛️ Sector-Specific 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗	FY 2009 Dec 31, 2008 10-K ↗	FY 2008 Dec 31, 2007 10-K ↗
FFO (approx.) (USD)	$223.12M	$209.43M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FFO per Share (approx.) (USD)	$4.76	$4.78	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 65 quarters

NATIONAL HEALTH INVESTORS INC

Analytical Summary

18-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NHI with peers